Perrigo Guides Lower Sales as Retailers Hold Stock

Consumer-goods suppliers should expect slower restocking while retailers stay cautious on inventory.

Updated on Nov. 6, 2026 in Consumer Goods

Bold flat-color editorial illustration of a stack of plain shipping containers in a sparse yard under a clear sky, in deep red, cream, and navy.
Perrigo cut its 2026 adjusted EPS outlook to $2.25 to $2.45 and agreed to sell its infant formula unit to MeridianMade for $40 million upfront. AI Illustration. Upload story photo >

Perrigo set its 2026 all-in adjusted diluted EPS outlook at $2.25 to $2.45 and agreed to sell its infant formula unit to MeridianMade, a move that simplifies operations for consumer-goods suppliers. The infant formula unit is classified as discontinued operations.

Why it matters

Perrigo described the infant formula exit as a way to simplify operations, while cautious retailer inventories and continued softness among European consumers factored into its outlook. For consumer-goods operators, the combination signals that retailers are holding back on restocking even as suppliers prune businesses that had been consuming cash.

Perrigo's core reported net sales are guided to fall 2.5% to 3.6%, with adjusted operating margin of 14% to 15%. The infant formula sale to MeridianMade is worth up to $175 million, including $40 million upfront and up to $135 million tied to performance through 2030.

The players

Perrigo

Perrigo is a global consumer self-care products manufacturer whose portfolio spans over-the-counter medicines and personal care goods sold through major retailers.

MeridianMade

MeridianMade is the buyer of Perrigo's infant formula unit, acquiring the business for $40 million upfront plus performance-based payments.

The details

Perrigo classified its infant formula unit as discontinued operations, separating it from continuing results. The sale to MeridianMade pays $40 million at closing, with the remaining up to $135 million contingent on performance through 2030. Retailer inventory caution and softer European consumer demand were cited as factors in the company's outlook.

Timeline

  1. 2026: Perrigo sets its all-in adjusted diluted EPS outlook at $2.25 to $2.45.

  2. Through 2030: Performance period governing up to $135 million in additional sale payments.

Market Landscape

Perrigo's exit from infant formula follows a pattern of consumer-goods companies divesting lines that consume cash to concentrate on core operations. The outlook's sales decline and cautious retailer inventories point to a tougher near-term demand environment for suppliers in the category.

Consumer-goods operators should plan for slower replenishment orders while retailers hold back inventory, with timing uncertain between the fourth quarter and first quarter. Suppliers reviewing their own product lines may find the divestiture of cash-consuming units a practical model to weigh against their core margins.

The takeaway

Watch whether retailer restocking picks up as the season strengthens, since the timing of that replenishment is the key swing factor in Perrigo's outlook. Operators should track sales trends and margin guidance in their own categories against this softer retail backdrop.

Further reading

Explore more coverage in the Consumer Goods section for context on how suppliers are adjusting portfolios and outlooks.

Source note: This article includes information reported by TokenPost.